Pfizer and 1,400 Jobs to Leave New London


Image: Pfizer

Pfizer, the anchor tenant (but not a party to) the redevelopment project that led to Kelo v. New London and the expansion of government powers of eminent domain, is bailing out of New London. That the company took New London’s tax incentives and now is leaving the Connecticut city high and dry should come as no surprise to Brooklynites.

Pfizer announced last year that it was closing its Brooklyn operationswhere the company was founded 160 years ago. This despite the fact that the company had accepted $46 million in tax breaks from the City to bring jobs to New York.

And just to show how classy they are, on its way out of Brooklyn Pfizer demolished the red brick building that had served as its first laboratory, office, factory and warehouse (pictured above).